June 2023

(LARGO, FL) PharmaLink, Inc., an Industry-leading pharmaceutical reverse distributor, announced today a new contract relationship with biopharmaceutical manufacturer Merck Sharp & Dohme LLC (Merck). The new Returns Processing Service Agreement is expected to enhance the returns process for downstream customers while maintaining the integrity of supply chain security.

(LARGO, FL) PharmaLink, Inc., a leading pharmaceutical reverse distributor, announced today its acquisition of Cybornetic Systems, Inc. dba PharmaReturns, Inc. In addition to expanding its national account base with top tier clients, the purchase provides PharmaLink with an innovative technology platform for returns processing that adds Artificial Intelligence (AI) and new levels of customization to the reverse distribution process for pharmaceutical manufacturers. The Internet Managed Product Returns Solution (IMPRS) currently supports returns processing operations for over 400 Pharmaceutical manufacturers in the United States.